Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
15 people injured in shooting during Oakland Juneteenth celebration
Program
On WRAL at 6: Case backlog: WRAL Investigates delays at NC morgue as families wait for closure
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
9
Next >
Unveiling 5 Analyst Insights On Editas Medicine
June 18, 2024
Tickers
EDIT
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
The Analyst Verdict: Editas Medicine In The Eyes Of 4 Experts
May 30, 2024
Tickers
EDIT
Tags
Analyst Ratings
BZI/AAR
EDIT
From
Benzinga
Overlooked and Undervalued: 3 Stocks With Jaw-Dropping Upside Potential
May 30, 2024
Tickers
CNXC
EDIT
Z
Tags
CNXC
Market News
Uncategorized
From
InvestorPlace
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
May 09, 2024
Tickers
C
EDIT
Tags
Recent Press Releases
Market News
C
From
Motley Fool
EDIT Stock Earnings: Editas Medicine Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
Tickers
EDIT
Tags
EDIT
Market News
Earnings Reports
From
InvestorPlace
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
March 07, 2024
Tickers
EDIT
Tags
Recent Press Releases
Market News
EDIT
From
Motley Fool
1 Beaten-Down Stock With 55% Upside, According to Wall Street
March 04, 2024
Tickers
EDIT
Tags
EDIT
Recent Press Releases
Market News
From
Motley Fool
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
March 02, 2024
Tickers
C
EDIT
VRTX
Tags
VRTX
Recent Press Releases
Market News
From
Motley Fool
The Latest Analyst Ratings For Editas Medicine
February 29, 2024
Tickers
EDIT
Tags
Analyst Ratings
EDIT
BZI/AAR
From
Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Tickers
AAP
ACMR
ADIL
ADT
Tags
BMBL
TGTX
Top Gainers
From
Benzinga
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
February 28, 2024
Tickers
AAP
ACMR
ADT
ADY
Tags
Benzinga
RVLV
FLYW
From
Benzinga
Earnings Outlook For Editas Medicine
February 27, 2024
Tickers
EDIT
Tags
BZI/EP
EDIT
Benzinga
From
Benzinga
2 Under-the-Radar Stocks With Incredible Upside Potential
January 28, 2024
Tickers
EDIT
RXRX
Tags
EDIT
RXRX
Recent Press Releases
From
Motley Fool
Could Editas Medicine Become the Next CRISPR Therapeutics?
January 21, 2024
Tickers
CRSP
EDIT
Tags
Recent Press Releases
Market News
CRSP
From
Motley Fool
7 Mighty Healthcare Stocks Changing the Game of Medicine
January 17, 2024
Tickers
ASXC
EDIT
HOLX
ILMN
Tags
ASXC
VERV
Stocks to Buy
From
InvestorPlace
Down 88%, Could Editas Medicine Be a Good Investment Now?
January 15, 2024
Tickers
CRSP
EDIT
VRTX
Tags
VRTX
CRSP
Recent Press Releases
From
Motley Fool
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
Tickers
BEAM
EDIT
LLY
VERV
Tags
Stocks to Buy
EDIT
VERV
From
InvestorPlace
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
January 08, 2024
Tickers
EDIT
NTLA
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
December 23, 2023
Tickers
EDIT
VRTX
Tags
VRTX
Recent Press Releases
Market News
From
Motley Fool
Vertex’s stock heads for all-time high as non-opioid painkiller shows promise
December 13, 2023
Tickers
EDIT
SPX
VRTX
VTRS
Tags
EDIT
VTRS
VRTX
From
MarketWatch
The Latest Analyst Ratings for Editas Medicine
December 12, 2023
Tickers
EDIT
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
Tickers
BLUE
CRSP
EDIT
VRTX
Tags
EDIT
BLUE
VRTX
From
MarketWatch
1 Promising Stock Down 66% That Could Skyrocket in 2024
December 05, 2023
Tickers
EDIT
Tags
EDIT
Market News
Recent Press Releases
From
Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
Tickers
ARKG
BEAM
CRBU
CRSP
Tags
ARKG
EDIT
VERV
From
Motley Fool
If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names
November 29, 2023
Tickers
BLUE
EDIT
GPCR
Tags
NASDAQ:EDIT,NASDAQ:BLUE,NASDAQ:GPCR
EDIT
Stocks to Buy
From
InvestorPlace
Hidden Gems for Hefty Returns: 3 Stocks Set to Double Your Wealth Next Year
November 22, 2023
Tickers
AMD
EDIT
MARA
Tags
MARA
EDIT
Stocks to Buy
From
InvestorPlace
The 3 Best Gene Editing Stocks on the Frontier of Medicine
November 20, 2023
Tickers
ARKG
BEAM
EDIT
Tags
Market News
BEAM
NASDAQ:EDIT,CBOE:ARKG,NASDAQ:BEAM
From
InvestorPlace
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street
November 20, 2023
Tickers
AAPL
BLUE
CRSP
EDIT
Tags
Market News
BLUE
GOOG
From
Motley Fool
3 Long-Term Growth Stocks Analysts Are Bullish On
November 16, 2023
Tickers
CRSP
EDIT
NVDA
SQ
Tags
Market News
NASDAQ:NVDA,NYSE:SQ,NASDAQ:EDIT,NASDAQ:CRSP
NVDA
From
InvestorPlace
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
Tickers
CRSP
EDIT
NTLA
REGN
Tags
Market News
VRTX
CRSP
From
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.